through to the intravascular catheter [3] . Unfortunately, the mechanical features and performances of IV delivery system components can go unappreciated [4] . In their report, Kuntz and colleagues describe a careful investigation of the properties of one component of an infusion system, the administration port [5] . They measured the dead volumes of administration ports with different designs (Y tubing, stopcocks, 1-way ports). The findings from their quantitative in vitro model demonstrate a wide range of dead volumes. These dead volumes can provide reservoirs of drugs available for inadvertent bolus. With this information, they provide estimates of potential unintended bolus doses of powerful medications including epinephrine, heparin and insulin. As Kuntz et al. point out, there are major implications for pediatric patients. This is true because the same infusion system components, e.g. stopcocks, may be used for both pediatric and adult patients. However, the tolerance of a 2-3 kg infant is vastly different than a 70-80 kg adult for the same mass of drug. Imagine the implications of a bolus of epinephrine, 8 μg, for the infant versus an adult. Errors associated with the dead volumes of injection ports potentially amplify the impact of errors with injections of small volumes [6] .
Kuntz et al. also explore the implications of the dead volume for blood sampling. The data provide insights into the impact of dead volume on clinical assessment of key patient parameters including oxygenation, ventilation and hematocrit, again with particular implications for the small patient.
One might hope that clinical practice would account for infusion system component dead volumes, thereby mitigating risks for adverse events. Distressingly, the survey data suggest variations in clinical practice even within one department. An overall inference is that clinical practice may fail to provide safeguards [7] , perhaps because of lack of awareness of pitfalls or the distraction of stressful clinical circumstances such as hemorrhage or an unstable cardiac condition. Furthermore, hospitals may change suppliers of IV system components because of cost or manufacturer shortfalls. Will clinicians recognize the potential for unfamiliar mechanical properties of components from alternative suppliers and adjust their practices accordingly?
Adverse patient care events motivated the studies conducted by Kuntz 
